Concepedia

Publication | Closed Access

Oral l‐ornithine‐l‐aspartate in minimal hepatic encephalopathy: A randomized, double‐blind, placebo‐controlled trial

59

Citations

17

References

2013

Year

Abstract

A 60-day oral LOLA course was not better than placebo in treating MHE, but was useful in preventing further episodes of OHE.

References

YearCitations

Page 1